[Patient with reactivation of hepatitis B after chemotherapy. Role of lamivudine therapy].
Maciá Escalante
Sonia
S
Rodríguez Lescure
Alvaro
A
García Sepulcre
Mariana Fe
MF
Guillén Ponce
Carmen
C
Carrato Mena
Alfredo
A
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D005260:Female; D006510:Hepatitis B Antibodies / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D014775:Virus Activation
D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine